Autophagy has been shown to be a mechanism of resistance to several chemotherapeutic agents, such as tyrosine kinase inhibitors and monoclonal antibodies targeting the EGFR and VEGFR signaling pathways in multiple solid tumor models including NSCLC. This evidence concerns the gene KDR and non-small cell lung carcinoma.